Silo Pharma, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Silo Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to Q1 2024.
  • Silo Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$115K.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$471K, a 110% decline from 2022.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.94M, a 30.2% increase from 2021.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.79M, a 77.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$115K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2021 $3.8M +$3.78M +25210% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $15K +$24.8K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 -$9.81K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2013 $20K +$5K +33.3% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 $15K +$14.4K +2509% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $575 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $8.5K Jul 13, 2010 Sep 30, 2010 10-Q 2011-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.